Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma

Purpose. Colon adenocarcinoma (COAD) is the third most common malignancy globally and is further categorized as left colon adenocarcinoma (LCOAD) or right colon adenocarcinoma (RCOAD) depending on the location of the primary tumor. The therapeutic outcome and long-term prognosis for patients with CO...

Full description

Bibliographic Details
Main Authors: Jing Han, Xue Zhang, Yang Yang, Li Feng, Gui-Ying Wang, Nan Zhang
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/8465068
id doaj-dd25b3d6da28416eb2cab845a218a15e
record_format Article
spelling doaj-dd25b3d6da28416eb2cab845a218a15e2020-11-24T21:39:51ZengHindawi LimitedBioMed Research International2314-61332314-61412020-01-01202010.1155/2020/84650688465068Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon AdenocarcinomaJing Han0Xue Zhang1Yang Yang2Li Feng3Gui-Ying Wang4Nan Zhang5Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, ChinaDepartment of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, ChinaSecond Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, ChinaDepartment of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, ChinaSecond Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, ChinaDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, ChinaPurpose. Colon adenocarcinoma (COAD) is the third most common malignancy globally and is further categorized as left colon adenocarcinoma (LCOAD) or right colon adenocarcinoma (RCOAD) depending on the location of the primary tumor. The therapeutic outcome and long-term prognosis for patients with COAD are less than satisfactory, and this may be associated with tumor location. Therefore, it is important to investigate the genetic differences in COAD at different sites. Patients and Methods. Public data associated with COAD were downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified using R software (version 3.5.3), and functional annotation of DEGs was performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. A protein-protein interaction network was constructed, hub genes were identified and analyzed, and data mining using Gene Expression Profiling Interactive Analysis (GEPIA) was conducted. Results. A total of 286 DEGs were identified between LCOAD and RCOAD. Additionally, 10 hub genes associated with COAD at different locations were screened, namely, CDKN2A, IGF1R, MDM2, SMAD3, SLC2A1, GRM5, PLCB4, FGFR1, UBE2V2, and TNFRSF10B. The expression of cyclin-dependent kinase inhibitor 2A (CDKN2A) and solute carrier family 2 member 1 (SLC2A1) was significantly associated with pathological stage P<0.05. COAD patients with high expression levels of CDKN2A exhibited poorer overall survival (OS) times than those with low expression levels P<0.05. Conclusion. CDKN2A expression was significantly different between LCOAD and RCOAD and was closely related to the prognosis of COAD. It is of great value for further understanding of the pathogenesis of LCOAD and RCOAD.http://dx.doi.org/10.1155/2020/8465068
collection DOAJ
language English
format Article
sources DOAJ
author Jing Han
Xue Zhang
Yang Yang
Li Feng
Gui-Ying Wang
Nan Zhang
spellingShingle Jing Han
Xue Zhang
Yang Yang
Li Feng
Gui-Ying Wang
Nan Zhang
Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma
BioMed Research International
author_facet Jing Han
Xue Zhang
Yang Yang
Li Feng
Gui-Ying Wang
Nan Zhang
author_sort Jing Han
title Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma
title_short Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma
title_full Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma
title_fullStr Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma
title_full_unstemmed Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma
title_sort screening and identification of differentially expressed genes expressed among left and right colon adenocarcinoma
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2020-01-01
description Purpose. Colon adenocarcinoma (COAD) is the third most common malignancy globally and is further categorized as left colon adenocarcinoma (LCOAD) or right colon adenocarcinoma (RCOAD) depending on the location of the primary tumor. The therapeutic outcome and long-term prognosis for patients with COAD are less than satisfactory, and this may be associated with tumor location. Therefore, it is important to investigate the genetic differences in COAD at different sites. Patients and Methods. Public data associated with COAD were downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified using R software (version 3.5.3), and functional annotation of DEGs was performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. A protein-protein interaction network was constructed, hub genes were identified and analyzed, and data mining using Gene Expression Profiling Interactive Analysis (GEPIA) was conducted. Results. A total of 286 DEGs were identified between LCOAD and RCOAD. Additionally, 10 hub genes associated with COAD at different locations were screened, namely, CDKN2A, IGF1R, MDM2, SMAD3, SLC2A1, GRM5, PLCB4, FGFR1, UBE2V2, and TNFRSF10B. The expression of cyclin-dependent kinase inhibitor 2A (CDKN2A) and solute carrier family 2 member 1 (SLC2A1) was significantly associated with pathological stage P<0.05. COAD patients with high expression levels of CDKN2A exhibited poorer overall survival (OS) times than those with low expression levels P<0.05. Conclusion. CDKN2A expression was significantly different between LCOAD and RCOAD and was closely related to the prognosis of COAD. It is of great value for further understanding of the pathogenesis of LCOAD and RCOAD.
url http://dx.doi.org/10.1155/2020/8465068
work_keys_str_mv AT jinghan screeningandidentificationofdifferentiallyexpressedgenesexpressedamongleftandrightcolonadenocarcinoma
AT xuezhang screeningandidentificationofdifferentiallyexpressedgenesexpressedamongleftandrightcolonadenocarcinoma
AT yangyang screeningandidentificationofdifferentiallyexpressedgenesexpressedamongleftandrightcolonadenocarcinoma
AT lifeng screeningandidentificationofdifferentiallyexpressedgenesexpressedamongleftandrightcolonadenocarcinoma
AT guiyingwang screeningandidentificationofdifferentiallyexpressedgenesexpressedamongleftandrightcolonadenocarcinoma
AT nanzhang screeningandidentificationofdifferentiallyexpressedgenesexpressedamongleftandrightcolonadenocarcinoma
_version_ 1716682016581222400